Medication for ADHD in Australia: What You Need to Know.

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition affecting about 6–10% of Australian children and 2–6% of adults. It can significantly impact learning, relationships, and daily life. In recent years, awareness and diagnosis rates have risen sharply, leading to a surge in ADHD medication prescriptions across the country

Stimulants are the most commonly prescribed ADHD medications. These include:

• Methylphenidate (brands: Ritalin, Concerta)
• Amphetamines (brands: Dexamphetamine, Vyvanse)
• Non-stimulant options are also available, such as:

1. Atomoxetine (Strattera)
2. Guanfacine (Intuniv)

Stimulants work by increasing certain brain chemicals that help with focus and impulse control, while non-stimulants target different pathways and may be preferred for some individuals.

ADHD medications in Australia are tightly regulated. Most require a prescription from a specialist (such as a paediatrician or psychiatrist), and in many states, special permits are needed.

The Therapeutic Goods Administration (TGA) oversees the safety and supply of these medicines.

Since 2021, adults can also access some ADHD medications through the Pharmaceutical Benefits Scheme (PBS), making treatment more affordable for eligible patients.

Research shows that stimulant medications like methylphenidate and dexamfetamine are generally effective for reducing ADHD symptoms in both children and adults. However, individual responses vary, and finding the right medication and dose often involves some trial and error.

A comprehensive treatment plan-including behavioral support and lifestyle changes-offers the best outcomes.